Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis

Shogo Matsuda1, Katsumasa Oe1, Takuya Kotani1

  • 1Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.

Insights

High serum creatinine and C4 levels are key risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). Monitoring these markers aids in predicting ESRD progression in MPA patients.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) is a systemic vasculitis that can affect the kidneys.
  • End-stage renal disease (ESRD) is a severe complication of MPA, necessitating identification of predictive factors.

Purpose of the Study:

  • To identify risk factors for the progression to ESRD in patients with microscopic polyangiitis.
  • To evaluate the utility of serum C4 and creatinine levels in predicting renal outcomes in MPA.

Main Methods:

  • Retrospective analysis of 74 MPA patients comparing those with and without ESRD.
  • Multivariate logistic regression and receiver operating characteristic (ROC) analyses to identify predictive factors and cut-off values.

Main Results:

  • 16.2% of MPA patients developed ESRD during follow-up.
  • Elevated serum C4 (p=0.009) and serum creatinine levels were significantly associated with ESRD.
  • High serum creatinine (OR 4.4) and serum C4 (OR 1.24) were identified as independent risk factors for ESRD.

Conclusions:

  • Serum C4 and creatinine levels are valuable predictors of ESRD in MPA patients.
  • Specific cut-off values (C4: 29.6 mg/dL, Creatinine: 3.54 mg/dL) can help stratify ESRD risk.
  • Serum C4 levels correlate with renal disease activity and prognosis in MPA.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
102
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
99
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
24
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
18